BioCentury | Apr 11, 2016
Company News

Interpace Diagnostics, Galaxy Health sales and marketing update

...cover all of Interpace’s molecular pathology tests and services. Interpace’s portfolio includes cancer risk-stratifying assays ThyGenX...
BioCentury | Jun 13, 2013
Distillery Techniques

Technology: Drug platforms

...thymic epithelial cells in mouse models. Corresponding authors Matthias Hebrok and Mark Anderson have cofounded ThyGen...
...approach. SciBX 6(23); doi:10.1038/scibx.2013.586 Published online June 13, 2013 Patent application filed; exclusively licensed to ThyGen...
Items per page:
1 - 2 of 2